Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Arcutis Biotherapeutics, Inc. (ARQT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
4 Mar 2024
Heron Patrick J
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
8,785,284
+0%
21,052
$9.50
$199,994.00
SELL
4 Mar 2024
Moore Matthew Richard
SVP and Chief Business Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
146,020
-2%
3,468
$11.12
$38,568.32
SELL
4 Mar 2024
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
874,533
-1%
14,903
$11.12
$165,739.23
SELL
4 Mar 2024
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
269,300
-1%
4,782
$11.12
$53,181.58
SELL
4 Mar 2024
Matsuda Masaru
See Remark, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
190,424
-1%
3,760
$11.12
$41,815.71
SELL
28 Feb 2024
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
889,436
-0%
2,465
$10.60
$26,129.00
SELL
2 Jan 2024
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
57,032
-2%
1,325
$3.54
$4,691.56
BUY
24 Oct 2023
Frazier Life Sciences VIII, L.P.
10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
8,764,232
+0%
80,000
$2.50
$200,000.00
SELL
15 Sep 2023
Josh Gottheimer
Congressman (House)
Arcutis Biotherapeutics, Inc.
(ARQT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
18 Aug 2023
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
59,662
-2%
1,605
$7.04
$11,302.20
SELL
27 May 2023
Matsuda Masaru
See Remark, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
42,146
-4%
1,830
$7.80
$14,278.21
SELL
17 Apr 2023
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
165,825
-4%
8,500
$13.97
$118,728.00
BUY
17 Apr 2023
Josh Gottheimer
Congressman (House)
Arcutis Biotherapeutics, Inc.
(ARQT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
6 Apr 2023
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
165,825
-4%
8,500
$12.01
$102,085.00
SELL
2 Mar 2023
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
39,836
-4%
1,751
$15.83
$27,713.12
SELL
2 Mar 2023
Matsuda Masaru
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
18,119
-7%
1,434
$15.83
$22,695.79
SELL
2 Mar 2023
Moore Matthew Richard
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
11,711
-12%
1,610
$15.83
$25,481.25
SELL
28 Feb 2023
Burrows Scott L
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
38,424
-4%
1,850
$15.90
$29,421.25
SELL
28 Feb 2023
Lock Kenneth A.
Chief Commercial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
43,278
-5%
2,368
$15.96
$37,795.95
SELL
28 Feb 2023
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
254,659
-0%
2,005
$15.96
$32,002.07
SELL
28 Feb 2023
Turney Patricia A.
SVP, Operations, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
45,711
-4%
2,368
$15.96
$37,796.09
SELL
28 Feb 2023
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
369,161
-2%
7,815
$15.93
$124,483.26
SELL
15 Feb 2023
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
165,825
-4%
8,500
$16.98
$144,352.10
SELL
13 Feb 2023
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
377,007
-0%
1,000
$17.01
$17,011.76
SELL
1 Feb 2023
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
378,289
-0%
1,000
$17.00
$17,002.72
SELL
17 Jan 2023
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
165,825
-4%
8,500
$13.72
$116,654.85
SELL
3 Jan 2023
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
41,564
-3%
1,475
$15.01
$22,136.06
SELL
7 Dec 2022
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
378,907
-0%
1,000
$17.06
$17,060.00
SELL
18 Nov 2022
Matsuda Masaru
See Remark, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
19,535
-8%
1,720
$18.19
$31,288.87
SELL
15 Nov 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
165,825
-2%
3,403
$20.01
$68,102.54
SELL
7 Nov 2022
Watanabe Todd Franklin
See Remarks, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
379,907
-0%
1,000
$18.00
$18,004.00
SELL
7 Oct 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
380,907
-0%
1,000
$19.51
$19,510.00
SELL
4 Oct 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
168,208
-3%
6,000
$20.29
$121,766.40
SELL
7 Sep 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
381,907
-0%
1,000
$21.51
$21,510.00
SELL
18 Jul 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
180,208
-3%
6,000
$24.40
$146,373.60
SELL
8 Jul 2022
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
256,649
-0%
2,197
$25.41
$55,835.44
SELL
8 Jul 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
656,784
-2%
13,500
$25.37
$342,472.80
SELL
6 Jul 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
658,284
-0%
1,000
$22.07
$22,070.00
SELL
24 Jun 2022
ORBIMED ADVISORS LLC
10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
3,534,537
-8%
341,971
$21.31
$7,287,401.50
BUY
15 Jun 2022
Josh Gottheimer
Congressman (House)
Arcutis Biotherapeutics, Inc.
(ARQT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
6 Jun 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
659,284
-0%
1,000
$21.06
$21,064.00
SELL
1 Jun 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$20.62
$51,538.50
SELL
27 May 2022
Matsuda Masaru
SVP and General Counsel, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
16,380
-9%
1,795
$19.73
$35,418.58
SELL
5 May 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
658,667
-0%
1,000
$21.76
$21,760.00
SELL
2 May 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$20.44
$51,112.00
SELL
21 Apr 2022
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
257,229
-0%
2,197
$20.42
$44,872.18
SELL
6 Apr 2022
ORBIMED ADVISORS LLC
10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
3,840,564
-18%
878,200
$20.68
$18,163,608.00
SELL
5 Apr 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
659,667
-0%
1,000
$21.43
$21,430.00
SELL
1 Apr 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-3%
7,500
$20.02
$150,183.75
SELL
9 Mar 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
660,667
-0%
300
$17.00
$5,100.00
SELL
3 Mar 2022
Burrows Scott L
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
35,256
-0%
303
$16.85
$5,104.17
SELL
3 Mar 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
660,967
-0%
3,259
$16.90
$55,087.51
SELL
3 Mar 2022
Burnett Patrick
See Remarks, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
43,039
-2%
1,011
$16.85
$17,032.13
SELL
3 Mar 2022
Lock Kenneth A.
Chief Commercial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
44,011
-2%
1,023
$16.85
$17,234.43
SELL
3 Mar 2022
Turney Patricia A.
SVP, Operations, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
31,113
-3%
1,023
$16.85
$17,234.43
SELL
3 Mar 2022
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
259,426
-0%
856
$16.85
$14,419.79
SELL
1 Mar 2022
Burrows Scott L
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
22,259
-1%
420
$17.75
$7,456.13
SELL
1 Mar 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
592,626
-0%
2,153
$17.75
$38,221.57
SELL
1 Mar 2022
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
246,982
-0%
775
$17.75
$13,758.34
SELL
1 Mar 2022
Turney Patricia A.
SVP, Operations, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
18,836
-4%
936
$17.75
$16,616.53
SELL
1 Mar 2022
Lock Kenneth A.
Chief Commercial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
31,734
-2%
935
$17.75
$16,598.78
SELL
9 Feb 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,000
$17.00
$17,000.00
SELL
5 Jan 2022
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
595,479
-0%
1,000
$21.59
$21,592.00
SELL
3 Jan 2022
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$21.21
$53,029.50
SELL
27 Dec 2021
Burrows Scott L
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
22,679
-35%
12,560
$20.07
$252,139.50
SELL
23 Dec 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$20.16
$50,395.50
SELL
8 Dec 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,000
$17.00
$17,000.00
SELL
5 Nov 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,000
$21.50
$21,501.60
SELL
1 Nov 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$21.81
$54,524.00
SELL
5 Oct 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
2,500
$24.92
$62,293.50
SELL
1 Oct 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,500
$23.87
$59,679.75
SELL
1 Oct 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,500
$25.01
$37,510.05
SELL
7 Sep 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,000
$21.14
$21,137.00
SELL
1 Sep 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
182,696
-2%
5,000
$20.80
$103,986.46
SELL
5 Aug 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,000
$20.81
$20,810.00
SELL
6 Jul 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,750
$26.58
$46,515.00
SELL
1 Jul 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
182,146
-1%
2,200
$26.13
$57,475.83
SELL
24 Jun 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
841,391
-0%
7,484
$27.50
$205,810.00
SELL
21 Jun 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
848,875
-0%
2,516
$27.50
$69,190.00
SELL
7 Jun 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
594,779
-0%
1,750
$26.35
$46,112.50
SELL
1 Jun 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
212,695
-1%
2,200
$27.09
$59,602.71
SELL
1 Jun 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
851,391
-1%
10,000
$27.50
$275,000.00
SELL
7 May 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
593,773
-0%
750
$35.00
$26,250.00
SELL
5 May 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
593,773
-0%
1,750
$34.00
$59,500.00
SELL
3 May 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
211,858
-1%
2,200
$34.79
$76,547.40
SELL
30 Apr 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
593,916
-0%
1,500
$35.00
$52,500.00
SELL
20 Apr 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
862,671
-1%
10,000
$28.06
$280,568.20
SELL
5 Apr 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
595,416
-0%
1,750
$29.93
$52,377.50
SELL
1 Apr 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
209,326
-1%
2,200
$29.49
$64,880.20
SELL
22 Mar 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
876,383
-1%
10,000
$31.10
$311,020.75
SELL
10 Mar 2021
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
46,321
-3%
1,750
$32.90
$57,575.00
SELL
3 Mar 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
597,166
-0%
1,750
$30.55
$53,462.50
SELL
2 Mar 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
566,216
-0%
2,107
$35.19
$74,136.06
SELL
1 Mar 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
205,799
-1%
2,200
$34.37
$75,609.91
SELL
1 Mar 2021
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
24,425
-3%
773
$34.20
$26,439.69
SELL
1 Mar 2021
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
237,253
-0%
780
$34.57
$26,967.72
SELL
1 Mar 2021
Turney Patricia A.
SVP, Operations, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
9,271
-9%
934
$34.52
$32,241.68
SELL
1 Mar 2021
Lock Kenneth A.
Chief Commercial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
22,167
-4%
933
$34.20
$31,907.76
SELL
22 Feb 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
884,180
-1%
10,000
$35.52
$355,190.94
SELL
10 Feb 2021
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
25,198
-9%
2,750
$35.64
$98,010.00
SELL
5 Feb 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
575,023
-1%
10,000
$34.29
$342,915.66
SELL
1 Feb 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
184,768
-1%
2,200
$34.35
$75,572.23
SELL
1 Feb 2021
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
25,198
-16%
5,000
$35.00
$175,000.00
SELL
29 Jan 2021
CHAUDHURI BHASKAR
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
891,391
-1%
10,000
$33.22
$332,206.75
SELL
19 Jan 2021
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
25,198
-6%
1,750
$30.00
$52,500.00
SELL
5 Jan 2021
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
566,928
-0%
3,000
$30.00
$90,000.00
SELL
4 Jan 2021
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,896
-1%
2,200
$27.82
$61,214.56
SELL
14 Dec 2020
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
25,198
-17%
5,250
$30.00
$157,500.00
SELL
14 Dec 2020
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
250,533
-5%
15,000
$30.00
$450,000.00
SELL
1 Dec 2020
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
181,157
-1%
2,200
$25.98
$57,154.57
SELL
2 Nov 2020
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
178,622
-1%
2,200
$18.27
$40,186.08
BUY
2 Oct 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
4,267,564
+13%
496,000
$25.00
$12,400,000.00
BUY
2 Oct 2020
SILVERSTEIN JONATHAN
Director, 10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
4,267,564
+13%
496,000
$25.00
$12,400,000.00
SELL
1 Oct 2020
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
177,400
-1%
2,200
$27.65
$60,828.86
SELL
29 Sep 2020
Smither John W
Chief Financial Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
23,875
-6%
1,750
$30.00
$52,500.00
SELL
29 Sep 2020
Watanabe Todd Franklin
President and CEO, Director, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
566,928
-0%
3,000
$30.00
$90,000.00
SELL
29 Sep 2020
OSBORNE DAVID W
Chief Technical Officer, Officer
Arcutis Biotherapeutics, Inc.
(ARQT)
264,279
-5%
15,000
$30.00
$450,000.00
SELL
1 Sep 2020
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
176,178
-1%
2,200
$24.38
$53,643.26
SELL
3 Aug 2020
Welgus Howard G.
Director
Arcutis Biotherapeutics, Inc.
(ARQT)
159,992
-1%
2,800
$25.63
$71,764.28
BUY
4 Feb 2020
Bain Capital Life Sciences Investors, LLC
10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
3,979,292
+7%
294,117
$17.00
$4,999,989.00
BUY
4 Feb 2020
Frazier Life Sciences VIII, L.P.
10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
10,542,790
+4%
500,000
$17.00
$8,500,000.00
BUY
4 Feb 2020
Heron Patrick J
Director, 10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
10,542,790
+4%
500,000
$17.00
$8,500,000.00
BUY
3 Feb 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
382,388
+316%
558,888
$17.00
$9,501,096.00
BUY
3 Feb 2020
SILVERSTEIN JONATHAN
Director, 10% Owner
Arcutis Biotherapeutics, Inc.
(ARQT)
382,388
+316%
558,888
$17.00
$9,501,096.00
Home